BTIG analyst Julian Harrison maintained a Buy rating on Jade Biosciences on April 2 and set a price target of $39.00. The company’s shares close...
BTIG analyst Julian Harrison maintained a Buy rating on Jade Biosciences on April 2 and set a price target of $39.00. The company’s shares close...